Parameter
| Biomarker | Ki-67 | Full name | Ki-67 antigen | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis | ||
| Disease | Non-Hodgkin Lymphoma (NHL) | Disease Subtypes | / | ||
| Organ | Lymphoid tissue | Test Sample / Technology Platform | Organization (Immunohistochemistry) | ||
| Pathobiological Mechanisms | High expression is associated with short survival and is widely used in pathological reports. | ||||
| Clinical Availability Status | Clinical validation phase: multicenter validation of value, staining scoring criteria to be standardized, routine pathological reference. | ||||
| Notes and Dynamics | Promote international unified scoring standards and explore the value of joint prediction.. | ||||